Honeywell International Inc. posted quarterly adjusted earnings of $2.25 per share, higher than the year-ago quarter’s $2.02 per share a year ago, and surpassing the Zacks Consensus Estimate of $2.16 per share (as reported in Zacks Equity Research).
Revenues of $8.95 billion, however, missed the Zacks Consensus Estimate by 1.37%. (as reported in Zacks Equity Research). It was $8.47 billion in the year-ago quarter. Organic sales rose +9%.
Honeywell’s Aerospace segment quarterly revenues grew +9% year over year. Building Technologies’ revenues rose +11% year-over-year, while Performance Materials and Technologies’ revenues total revenue increased +8%. Safety and Productivity Solutions revenues fell -7% owing to lower volumes in warehouse and workflow solutions and personal protective equipment.
For full-year 2022, Honeywell re-iterated its free cash flow expectation of $4.70-$5.10 billion. But it revised its forecast of operating cash flow to $5.20-$5.60 billion compared with prior estimate of $5.50-$5.90 billion. It now projects a segment margin of 21.6-21.8% (vs. prior forecast of 21.3-21.7%).
Honeywell now expects sales to be in the range of $35.40-$35.70 billion for 2022, compared with previous guidance of $35.50-$36.10 billion. Organic sales growth expectation is 6-7%, compared with previous projection of 5-7% .
The company now projects 2022 adjusted earnings per share in the range of $8.70-$8.80, boosting its outlook from prior forecast of $8.55-8.80.
HON saw its Momentum Indicator move below the 0 level on March 05, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 96 similar instances where the indicator turned negative. In of the 96 cases, the stock moved further down in the following days. The odds of a decline are at .
The 10-day RSI Indicator for HON moved out of overbought territory on March 03, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 62 cases where HON's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for HON turned negative on February 19, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HON declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where HON advanced for three days, in of 322 cases, the price rose further within the following month. The odds of a continued upward trend are .
HON may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In of 246 cases where HON Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. HON’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 70, placing this stock slightly better than average.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.804) is normal, around the industry mean (9.787). P/E Ratio (31.490) is within average values for comparable stocks, (34.855). Projected Growth (PEG Ratio) (2.164) is also within normal values, averaging (1.715). Dividend Yield (0.020) settles around the average of (0.029) among similar stocks. P/S Ratio (4.092) is also within normal values, averaging (3.136).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
an industrial conglomerate which operates as a diversified technology and manufacturing company
Industry IndustrialConglomerates